McKesson Corporation
McKesson Corporation Enters into $2.25 Billion Term Loan Facility
Summary
On June 9, 2026, McKesson Corporation's subsidiary, McKesson Medical-Surgical Top Holdings, Inc., entered into an amendment to its Credit Agreement to establish a $2.25 billion senior secured term 'B' loan facility due 2032. The loan will bear interest at a rate equal to either the Adjusted Term SOFR Rate plus 2.25% per annum or the Base Rate plus 1.25% per annum, with the initial interest rate set at the Adjusted Term SOFR Rate plus 2.25% per annum. The loan is secured by a security interest in substantially all tangible and intangible assets of the Borrower and certain material U.S. subsidiaries. The Credit Agreement also includes financial covenants for the Borrower.
Profitelligence Alerts
Get alerts for MCK
Be first to know when McKesson Corporation files with the SEC.
Filing Categories
Advertisement
About McKesson Corporation
McKesson Corporation is a leading healthcare services and information technology company. It plays a crucial role in the distribution of pharmaceuticals and medical products. The primary function of McKesson is to ensure the efficient delivery of healthcare products to pharmacies, hospitals, and other medical facilities, ensuring that millions of patients have access to the medications they need. It also provides specialized software and automated solutions that enhance operational efficiency in healthcare sectors. McKesson significantly impacts the pharmaceutical and healthcare industries by offering solutions that streamline supply chains and improve patient care. Its services encompass wholesale drug distribution, healthcare IT systems, and pharmacy management. With operations that extend globally, McKesson is integral to maintaining the integrity and reliability of healthcare supply networks. By handling a substantial portion of the pharmaceutical distribution in North America, McKesson Corporation has a vital market presence, emphasizing its importance in shaping healthcare logistics and innovation. Its efforts contribute to advancing healthcare delivery and responding to the evolving demands of the medical industry.
Official SEC Documents
Advertisement